Ludovic Brellier
EVP, Bioscience & Medtech · Avantor, Inc.
- 2026
- May 5, 2026
- 1
Summary
Latest filing:
Ludovic Brellier is EVP, Bioscience & Medtech of Avantor, Inc. (AVTR). 1 SEC Form 4 filing on record, dated 5 May 2026.
Recent transactions
1The latest SEC Form 4 transaction reported by Ludovic Brellier.
Trading pattern
InsiderAlpha's records for Ludovic Brellier go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ludovic Brellier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gregory L. Summe - $2.06M in AVTR purchases and sales in the last 12 months
- Sanjeev K. Mehra - $1.00M in AVTR purchases and sales in the last 12 months
- Emmanuel Ligner - $993K in AVTR purchases and sales in the last 12 months
- Gregory T. Lucier - $541K in AVTR purchases and sales in the last 12 months
- Simon Dingemans - $204K in AVTR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ludovic Brellier?
Ludovic Brellier is a corporate insider, tracked as EVP, Bioscience & Medtech of Avantor, Inc. (AVTR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ludovic Brellier last file a Form 4?
The only primary Form 4 on record is dated 5 May 2026.